CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Albuterol Sulfate HFA

albuterol sulfate· ingredient albuterolSelective beta-2-adrenoreceptor agonists· ALBUTEROL SULFATE 90 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$1.65
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per GM — the trend nobody else shows. 7 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other albuterol products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.

ProductNADAC / GMvs this
Albuterol Sulfate$0.03508−$1.62
albuterol sulfate$0.06535−$1.59
Ipratropium Bromide and Albuterol Sulfate$0.08739−$1.57
Albuterol Sulfate Inhalation Solution$0.22472−$1.43
Albuterol$0.32659−$1.33
Albuterol Sulfate Inhalation Solution, 0.5%$0.51281−$1.14
Albuterol$1.82+$0.16720
albuterol sulfate$2.14+$0.48740

Medicare Part D coverage · CY2026

On 326 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 92% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.